What is Integra LifeSciences's R&D?

Integra LifeSciences (IART) reported R&D of $23.5M in Q1 2026.

How has Integra LifeSciences's R&D changed year-over-year?

Integra LifeSciences's R&D decreased by 5.0% year-over-year, from $24.73M to $23.5M.

What is the long-term trend for Integra LifeSciences's R&D?

Over 4 years (2021 to 2025), Integra LifeSciences's R&D has grown at a 1.6% compound annual growth rate (CAGR), from $93.05M to $98.97M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

Integra LifeSciences IART R&D

R&D at other companies

Becton, Dickinson and CompanyBDX

$249M+7.3%

StrykerSYK

$413M+2.0%

AxogenAXGN

$7.52M+23.4%

MedtronicMDT

$671M-1.9%

STERISSTE

$28.8M+4.3%

ITG

Integer HoldingsITGR

$16.24M+14.4%

Segments

By segment

See full

Specialty Surgery$11.85M—

Tissue Reconstruction$7.53M—

Other financials

Income statement

See full

Revenue$391.9M+2.4%

Gross profit$217.0M+11.6%

Operating income$11.5M+174%

Net income-$4.6M+81.7%

EPS (diluted)-$0.06+81.8%

Balance sheet

See full

Cash & equivalents$236.8M-1.0%

Total debt$2.0B+3.2%

Total equity$1.0B-31.6%

Total assets$3.6B-11.7%

Cash flow

See full

Operating cash flow$9.8M+187%

CapEx$14.8M-48.7%

Free cash flow-$5.0M+87.4%

Valuation

See full

Market cap$1.38B-56.8%

Enterprise value$3.12B-26.7%

P/S0.8×-1.1×

Profitability

See full

Gross margin51.9%-1.6pp

Operating margin-29.8%-30.3pp

Net margin-30.1%—

FCF margin3.8%-6.3pp

Returns & leverage

See full

Return on equity-38.6%—

Debt / equity1.9×+0.6×

Current ratio3.4×+2.2×

Where this comes from

Reported directly by Integra LifeSciences in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost.

The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Integra LifeSciences's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Integra LifeSciences's R&D?: Integra LifeSciences (IART) reported R&D of $23.5M in Q1 2026.
How has Integra LifeSciences's R&D changed year-over-year?: Integra LifeSciences's R&D decreased by 5.0% year-over-year, from $24.73M to $23.5M.
What is the long-term trend for Integra LifeSciences's R&D?: Over 4 years (2021 to 2025), Integra LifeSciences's R&D has grown at a 1.6% compound annual growth rate (CAGR), from $93.05M to $98.97M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.